|
Tamoxifen Cuts Risk of Contralateral Breast Cancer.
OB GYN News; 3/1/2001; ZOLER, MITCHEL L.; 780 words
; Tamoxifen treatment for up to 4 years appeared to cut the risk ... 593 women, represents the first time that the effect of tamoxifen on the risk of breast cancer caused by BRCA1 and BRCA2 ... there is no biological difference in the efficacy of tamoxifen in breast cancers with and without BRCA1 and BRCA2 ...
Read more
|
|
|
NSABP's tamoxifen results confirmed.(News)
OB GYN News; 12/15/2005; Moon, Mary Ann; 601 words
; Tamoxifen substantially cuts the risk of invasive and noninvasive breast cancer, researchers ... followed for an additional 7 years. A total of 6,597 subjects composed the tamoxifen group and 6,610 formed the placebo group. All the benefits and risks of tamoxifen therapy that had been reported in the initial ...
Read more
|
|
Genistein inhibits tamoxifen effects on cell proliferation and cell cycle arrect in T47D breast cancer cells / Discussion
The American Surgeon; 6/1/2002; Jones, Julie L; Daley, Brian J; Enderson, Blaine L; Zhou, Jin-Rong; Et al; 787 words
; Tamoxifen is an antiestrogen used in the treatment of estrogen ... low-dose genistein would reverse the inhibitory effects of tamoxifen in estrogen-receptor-positive breast cancer cells. Cell ... cancer cells were examined after exposure to genistein and tamoxifen in a low-estrogen environment designed to mimic ...
Read more
|
|
Tamoxifen has stroke risk, review says; But threat is small, study of trials says
The Milwaukee Journal Sentinel; 10/12/2004; JOHN FAUBER; 580 words
; Tamoxifen has stroke risk, review says But threat is small, study of trials says The breast cancer drug tamoxifen appears to increase a woman's risk of having a stroke ... finding should not stop breast cancer patients from taking tamoxifen. But it could be a factor for women who are considering ...
Read more
|
|
Large study confirms tamoxifen's benefits, risks.
Internal Medicine News; 2/15/2006; Moon, Mary Ann; 598 words
; Tamoxifen substantially cuts the risk of invasive and noninvasive breast cancer, researchers ... followed for an additional 7 years. A total of 6,597 subjects composed the tamoxifen group and 6,610 formed the placebo group. All the benefits and risks of tamoxifen therapy that had been reported in the initial ...
Read more
|
|
A case of tamoxifen-induced hypertriglyceridemia
Indian Journal of Pharmacology; 9/1/2004; Gupta, S; Kapoor, B; Gupta, A; Tandon, V; 787 words
; Tamoxifen was originally known as an antiestrogen but subsequent ... low-density lipoprotein (LDL) and lipoprotein(a). Whereas tamoxifen is known to decrease total cholesterol (TC), LDL and ... in human beings.[1] Although, there are reports that tamoxifen leads to hypertriglyceridemia,[2],[3],[4] it is not ...
Read more
|
|
Tamoxifen 'breakthrough' a Bitter Pill to Swallow
Herizons; 7/1/1998; Anonymous; 787 words
; ... Institute study that hailed the cancer drug tamoxifen as a preventive treatment for women believed ... Canadian. Half of the subjects were given tamoxifen; half a placebo. Among the 6,500 taking tamoxifen, the breast cancer rate was 1.3% [85 ... placebo group, about 45% more than the tamoxifen group ... .
Read more
|
|
Tamoxifen slashes serum cholesterol ... but shows link to 'bad' uterine cancers. (drug used to prevent breast cancer recurrence)
Science News; 9/25/1993; 635 words
; ... then wanes. A potent hormone-like drug, tamoxifen poses some risks of its own. The leading ... all but brushed off the importance of tamoxifen-induced uterine cancers, charging that ... compared with the 56 women who did not take tamoxifen, the 15 who did were 4.7 times more likely ... these three uterine ...
Read more
|
|
New hope for women at risk.(tamoxifen may reduce breast cancer risk for some women)(Brief Article)
Newsweek; 4/20/1998; Begley, Sharon; 787 words
; The drug tamoxifen is the first compound ever shown to ... volunteered for the clinical trial of tamoxifen, a drug that preliminary data suggested ... by chance was in the group receiving tamoxifen rather than a placebo, that her luck ...
Read more
|
|
|
Tamoxifen decreases the incidence of benign breast disease. (Adenosis, Cysts).
OB GYN News; 3/1/2002; Jancin, Bruce; 395 words
; SAN ANTONIO -- Tamoxifen markedly reduces the incidence of most ... breast cancer who were randomized to tamoxifen or placebo in the National Surgical ... this landmark trial demonstrated that tamoxifen reduced the incidence of invasive breast ...
Read more
|
